Increased Resistance to Oncostatin M-induced Growth Inhibition of Human Melanoma Cell Lines Derived from Advanced-Stage Lesions

Cancer Research

Volumn 53, Issue 12, 1993, Pages 2708-2711

  Lu, Chao ^a,d   Kerbel, Robert S ^a,b,c,d   Kobayashi, Hiroaki ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b Departments of Molecular and Medical Genetics   (Canada)

^c Medical Biophysics ^*  (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; ONCOSTATIN M;

ADVANCED CANCER; ARTICLE; CANCER CELL CULTURE; CANCER CONTROL; CANCER GROWTH; CANCER RESISTANCE; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL;

CELL DIVISION; DRUG RESISTANCE; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; GROWTH INHIBITORS; HUMAN; INTERLEUKIN-6; LYMPHOKINES; MELANOMA; NEOPLASM STAGING; PEPTIDES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0027276664     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. J. and Kerbel, R.S. Development of resistance mechanisms to the growth inhibitory effects of transforming growth factor-β during tumor progression. Curr. Opinion Oncol. 5: 123-129, 1993.
2. Kerbel, R.S. Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer: malignant melanoma as a paradigm. Am. J. Pathol. 141: 519-524, 1992.
3. Game, S.M. Huelsen, A. Patel, V. Donnelly, M. Yeudall, W.A. Stone, A. Fusenig, N.E. and Prime, S.S. Progressive abrogation of TGF-β1 and EGF growth control is associated with tumour progression in roj-transfected human keratinocytes. Int. J. Cancer, 52: 461-470, 1992.
4. Jennings, M.T. Maciunas, R.J. Carver, R. Bascome, C.C. Juneau, P. Misulis, K. and Moses, H.L. TGF β1 and TGF β2 are potential growth regulators for low-grade and malignant gliomas in vitro: evidence in support of an autocrine hypothesis. Int. J. Cancer, 49: 129-139, 1991.
5. Hoosein, N.M. McKnight, M.K. Levine, A.E. Mulder, K.M. Childress, K.E. Brattain, D.E. and Brattain, M.G. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-β, Exp. Cell Res. 181: 442-453, 1989.
6. Yan, Z. Hus, S. Winawer, S. and Friedman, E. Transforming growth factor βi (TGF-β1) inhibits retinoblastoma gene expression but not pRB phosphorylation in TGF-β1 growth stimulated colon carcinoma cells. Oncogene, 7: 801-805, 1992.
7. Manning, A.M. Williams, A.C. Game, S.M. and Paraskeva, C. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β (TGF-β): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-β. Oncogene, 6: 1471-1476, 1991.
8. MacDougall, J. Kobayashi, H. and Kerbel, R.S. Responsiveness of normal/ dysplastic melanocytes and melanoma cells from different lesional stages of disease progression to the growth inhibitory effects of TGF-β. Mol. Cell. Differ. 1: 21-40, 1993.
9. Lu, CM Vickers, M.F. and Kerbel, R.S. Interleukin-6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc. Natl. Acad. Sci. USA, 89: 9215-9219, 1992.
10. Lu, C. and Kerbel, R.S. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J. Cell Biol. 120: 1281-1288, 1993.
11. Kerbel, R.S. Growth dominance of the metastatic cancer cell: cellular and molecular aspects. Adv. Cancer Res. 55: 87-132, 1990.
12. Brown, T.J. Lioubin, M.N. and Harquardt, H. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. J. Immunol. 139: 2977-2983, 1987.
13. Zarling, J.M. Shoyab, M. Marquardt, H. Hanson, M.B. Lioubin, M.N. and Todara, G.J. Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. Proc. Natl. Acad. Sci. USA, 83: 9739-9743, 1986.
14. Malik, N. Kallestad, J.C. Gunderson, N.L. Austin, S.D. Neubauer, M.G. Ochs, V. Marquardt, H. Zarling, J.M. Shoyab, M. Wei, C.M. Linsley, P.S. and Rose, T.M. Molecular cloning, sequencing analysis, and functional expression of a novel growth regulator, Oncostatin M. Mol. Cell. Biol. 9: 2847-2853, 1989.
15. Rose, T.M. and Bruce, A.G. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. Proc. Nad. Acad. Sci. USA, 88: 8641-8645, 1991.
16. Bazan, F. Neuropeptide cytokines in the hematopoietic fold. Neuron, 7: 197-208, 1991.
17. Gearing, D.P. Comeau, M.R. Friend, D.J. Gimpel, S.D. Thut, C.J. McGourty, J. Brasher, K.K. King, J.A. Gillis, S. Mosley, B. Ziegler, S.F. and Cosman, D. The IL-6 signal transducer, gp. 30: an oncostatin M receptor and affinity converter for the LIF receptor. Science (Washington DC), 255: 1434-1437, 1992.
18. Liu, J. Modrell, B. Aruffo, A. Marken, J.S. Taga, T. Yusukawa, K. Murakami, M. Kishimoto, T. and Shoyab, M. Interleukin-6 signal transducer gp. 30 mediates oncostatin M signaling. J. Biol. Chem. 267: 16763-16766, 1992.
19. Gearing, D.P. and Bruce, A.G. Oncostatin M binds the high-affinity leukemia inhibitory factor receptor. New Biol. 4: 61-65, 1992.
20. Bruce, A.G. Hoggatt, I.H. and Rose, T.M. Oncostatin M is a differentiation factor for myeloid leukemia cells. J. Immunol. 149: 1271-1275, 1992.
21. Miles, S.A. Martinez-Maza, O. Rezai, A. Magpantay, L. Kishimoto, T. Nakamura, S. Radka, S.F. and Linsley, P.S. Oncostatin M as a potent mitogen for AIDs-Kaposi's sarcoma-derived cells. Science (Washington DC), 255: 1432-1434, 1992.
22. Nair, B.C. DeVico, A.L. Nakamura, S. Copeland, T.D. Chen, Y. Patel, A. O'Neil, T. Oroszlan, S. Gallo, R.C. and Sarngadharan, M.G. Identification of a major growth factor for AIDs-Kaposi's sarcoma cells as Oncostatin M. Science (Washington DC), 255: 1430-1432, 1992.
23. Herlyn, M. Human melanoma: development and progression. Cancer Metastasis Rev. 9: 101-112, 1990.
24. Cornil, I. Theodorescu, D. Man, S. Herlyn, M. Jambrosic, J. and Kerbel, R.S. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc. Natl. Acad. Sci. USA, 88: 6028-6032, 1991.
25. Giard, D.J. Aaronson, S.A. Todaro, G.J. Arnstein, P. Kersey, J.H. Dosik, H. and Parks, W.P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51: 1417-1423, 1973.
26. Kishimoto, T. Akira, S. and Taga, T. Interleukin-6 and its receptor: a paradigm for cytokines. Science (Washington DC), 258: 593-597, 1992.
27. Clark, W H. Elder, D.E. Guerry, D. Braitman, L.E. Track, B.J. Schultz, D. Synnestvedt, M. and Halpem, A.C. Model predicting survival in stage I melanoma based on tumor progression. J. Natl. Cancer Inst. 81: 1983-1904, 1989.